Bart Reymen

3.4k citations

69 papers · 2.3k indexed · h-index 27

Impact in

Radiation top 1%
- Advanced Radiotherapy Techniques
Radiology, Nuclear Medicine and Imaging top 1%
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications

Papers in ⓘ

Radiation 20
- Advanced Radiotherapy Techniques 20
Radiology, Nuclear Medicine and Imaging 37
- Radiomics and Machine Learning in Medical Imaging 25
- Medical Imaging Techniques and Applications 24

Co-authors: Philippe Lambin (39 shared papers)Wouter van Elmpt (28 shared papers)Angela van Baardwijk (23 shared papers)Rinus Wanders (24 shared papers)Dirk De Ruysscher (22 shared papers)Anne‐Marie C. Dingemans (19 shared papers)Dirk De Ruysscher (26 shared papers)Ralph T. H. Leijenaar (8 shared papers)
Journals: Radiotherapy and Oncology (26 papers)Journal of Thoracic Oncology (7 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Annals of Oncology (4 papers)Acta Oncologica (4 papers)
Partner nations: Netherlands Belgium United Kingdom

In The Last Decade

Bart Reymen

65 papers receiving 2.3k citations

Peers

Countries citing papers authored by Bart Reymen

Since Specialization

Citations

This map shows the geographic impact of Bart Reymen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Reymen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Reymen more than expected).

Fields of papers citing papers by Bart Reymen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Reymen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Reymen. The network helps show where Bart Reymen may publish in the future.

Co-authors

The 25 scholars most cited alongside Bart Reymen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bart Reymen Line = papers co-authored together Bart Reymen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) Journal of Thoracic Oncology ·Dirk De Ruysscher, Rinus Wanders, Angela van Baardwijk, Anne‐Marie C. Dingemans, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Wiel Geraedts, Brigitta G. Baumert, Philippe Lambin	2012	211
2	Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome JNCI Journal of the National Cancer Institute ·Ahmed Salem, Marie‐Claude Asselin, Bart Reymen, Alan Jackson, Philippe Lambin, Catharine West, James P.B. O’Connor, Corinne Faivre‐Finn	2017	187
3	Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images Radiotherapy and Oncology ·Janita E. van Timmeren, Ralph T. H. Leijenaar, Wouter van Elmpt, Bart Reymen, Cary Oberije, René Monshouwer, Johan Bussink, Carsten Brink, Olfred Hansen, Philippe Lambin	2017	139
4	‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’ Radiotherapy and Oncology ·Philippe Lambin, Erik Roelofs, Bart Reymen, Emmanuel Rios Velazquez, Jeroen Buijsen, Catharina M.L. Zegers, Sara Carvalho, Ralph T. H. Leijenaar, Georgi Nalbantov, Cary Oberije, Michael S. Marshall, Frank Hoebers, Esther G.C. Troost, Ruud G.P.M. van Stiphout, Wouter van Elmpt, Trudy van der Weijden, Liesbeth Boersma, Vincenzo Valentini, André Dekker	2013	136
5	Current status of immune checkpoint inhibition in early-stage NSCLC Annals of Oncology ·Johan Vansteenkiste, Els Wauters, Bart Reymen, Christoph Ackermann, Solange Peters, Dirk De Ruysscher	2019	96
6	Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial Autophagy ·Inge Compter, Daniëlle B. P. Eekers, Ann Hoeben, Kasper M.A. Rouschop, Bart Reymen, Linda Ackermans, Jan Beckervordersantforth, Noël J.C. Bauer, Monique M. Anten, Pieter Wesseling, Alida A. Postma, Dirk De Ruysscher, Philippe Lambin	2020	89
7	Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review Radiotherapy and Oncology ·Angela van Baardwijk, Wolfgang A. Tomé, Wouter van Elmpt, Søren M. Bentzen, Bart Reymen, Rinus Wanders, Ruud Houben, Michel Öllers, Philippe Lambin, Dirk De Ruysscher	2012	79
8	A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making Radiotherapy and Oncology ·Cary Oberije, Georgi Nalbantov, André Dekker, Liesbeth Boersma, Jacques Borger, Bart Reymen, Angela van Baardwijk, Rinus Wanders, Dirk De Ruysscher, Ewout W. Steyerberg, Anne‐Marie C. Dingemans, Philippe Lambin	2014	75
9	In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging Clinical Cancer Research ·Catharina M.L. Zegers, Wouter van Elmpt, Bart Reymen, Aniek J.G. Even, Esther G.C. Troost, Michel Öllers, Frank Hoebers, Ruud Houben, Jonas Eriksson, Albert D. Windhorst, Felix M. Mottaghy, Dirk De Ruysscher, Philippe Lambin	2014	69
10	Hypoxia imaging with [18F]HX4 PET in NSCLC patients: Defining optimal imaging parameters Radiotherapy and Oncology ·Catharina M.L. Zegers, Wouter van Elmpt, Roel Wierts, Bart Reymen, Hoda Sharifi, Michel Öllers, Frank Hoebers, Esther G.C. Troost, Rinus Wanders, Angela van Baardwijk, Boudewijn Brans, Jonas Eriksson, Albert D. Windhorst, Felix M. Mottaghy, Dirk De Ruysscher, Philippe Lambin	2013	69
11	Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) Journal of Thoracic Oncology ·Dirk De Ruysscher, Rinus Wanders, Lizza Hendriks, Angela van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne‐Marie C. Dingemans	2018	63
12	Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion European Journal of Nuclear Medicine and Molecular Imaging ·Wouter van Elmpt, Catharina M.L. Zegers, Bart Reymen, Aniek J.G. Even, Anne‐Marie C. Dingemans, M. Oellers, Joachim E. Wildberger, Felix M. Mottaghy, Marco Das, Esther G.C. Troost, Philippe Lambin	2015	63
13	Comparative evaluation of autocontouring in clinical practice: A practical method using the Turing test Medical Physics ·Mark J. Gooding, Annamarie J. Smith, Maira Tariq, Paul Aljabar, Devis Peressutti, J. van der Stoep, Bart Reymen, Daisy Emans, Djoya Hattu, Judith van Loon, Maud de Rooy, Rinus Wanders, Stéphanie Peeters, Tim Lustberg, Johan van Soest, André Dekker, Wouter van Elmpt	2018	62
14	Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches Annals of Oncology ·Francesco Cortiula, Bart Reymen, Solange Peters, Pierre Van Mol, Els Wauters, Johan Vansteenkiste, Dirk De Ruysscher, Lizza Hendriks	2022	61
15	Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial Lung Cancer ·Ben J. Slotman, Corinne Faivre‐Finn, Harm van Tinteren, Astrid Keijser, J. Praag, J. Knegjens, M. Hatton, Iris van Dam, A. Van der Leest, Bart Reymen, Jos A. Stigt, Kate Haslett, Devashish Tripathi, Egbert F. Smit, Suresh Senan	2017	60
16	Feature selection methodology for longitudinal cone-beam CT radiomics Acta Oncologica ·Janita E. van Timmeren, Ralph T. H. Leijenaar, Wouter van Elmpt, Bart Reymen, Philippe Lambin	2017	58
17	Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence Radiotherapy and Oncology ·Janita E. van Timmeren, Wouter van Elmpt, Ralph T. H. Leijenaar, Bart Reymen, René Monshouwer, Johan Bussink, Leen Paelinck, E. Bogaert, Carlos De Wagter, Elamin Elhaseen, Yolande Lievens, Olfred Hansen, Carsten Brink, Philippe Lambin	2019	55
18	PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes Radiotherapy and Oncology ·Aniek J.G. Even, J. van der Stoep, Catharina M.L. Zegers, Bart Reymen, Esther G.C. Troost, Philippe Lambin, Wouter van Elmpt	2015	54
19	The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial) Radiotherapy and Oncology ·Judi van Diessen, Dirk De Ruysscher, Jan‐Jakob Sonke, E. Damen, Karolina Sikorska, Bart Reymen, Wouter van Elmpt, Gunnar Westman, Gitte Fredberg Persson, Edith Dieleman, Hedvig Björkestrand, Corinne Faivre‐Finn, J. Belderbos	2018	53
20	Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer European Journal of Cancer ·Angela van Baardwijk, Bart Reymen, S. Wanders, Jacques Borger, Michel Öllers, Anne‐Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Frank Peters, Philippe Lambin, Dirk De Ruysscher	2012	52

About Bart Reymen

Bart Reymen is a scholar working on Radiation, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Cancer Research, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (36 papers), Radiomics and Machine Learning in Medical Imaging (25 papers), Medical Imaging Techniques and Applications (24 papers), Lung Cancer Treatments and Mutations (24 papers), Advanced Radiotherapy Techniques (20 papers), Lung Cancer Research Studies (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Advanced X-ray and CT Imaging (4 papers). The work is most often cited by research in Radiation (451 citations), Radiology, Nuclear Medicine and Imaging (1.1k citations), Pulmonary and Respiratory Medicine (1.3k citations), Health Informatics (38 citations) and Cancer Research (374 citations). Bart Reymen has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Philippe Lambin, Wouter van Elmpt, Angela van Baardwijk, Rinus Wanders, Dirk De Ruysscher, Anne‐Marie C. Dingemans, Dirk De Ruysscher, Ralph T. H. Leijenaar, Ruud Houben and Gerben Bootsma. Their work appears in journals such as Radiotherapy and Oncology, Journal of Thoracic Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact